Browsing Tag

Lanier Biotherapeutics

Lanier Biotherapeutics Announces Issuance of U.S. Patent for IL-25 Binding Molecules

Eli Pacheco Nov 15, 2022 0

BOGART, Georgia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lanier Biotherapeutics Inc., (“Lanier” or the “Company”), a developer of first-in-class antibodies targeting retina, dermatology, Type 2…

Health

Lanier Biotherapeutics to Present Seminal LNR125 Publication at American Thoracic…

Eli Pacheco May 13, 2022 0

BOGART, Ga., May 13, 2022 (GLOBE NEWSWIRE) -- Lanier Biotherapeutics Inc., (“Lanier” or the “Company”), a developer of first-in-class antibodies targeting retina, dermatology, and Type 2…

Health

Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy…

Eli Pacheco Oct 5, 2021 0

BOGART, Ga., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Lanier Biotherapeutics Inc., (“Lanier” or the “Company”), a developer of first-in-class antibodies targeting retina, dermatology, and Type 2…